GSK plc
The role involves establishing pre-clinical capabilities for oligonucleotide synthesis at GSK, focusing on SPOS of modalities like ASOs and siRNA. Key activities include maintaining high-throughput automation workflows, developing novel chemistries, and collaborating with analytical and delivery chemistry teams to ensure high-quality results.
Headquarters
London, England, United Kingdom
Company Size
10001+ employees
Founded
1830
At GSK, we unite science, technology and talent to get ahead of disease together
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GSK plc.
71% above the average for this role
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
Senior Scientist (Oligonucleotide Conjugation)
Amgen
Group Leader, Oligonucleotides Chemistry
ASTARPRD
Principal Scientist I or II, Oligonucleotide Chemistry and Innovation
Novartis
Senior Associate Scientist
Regeneron Pharmaceuticals
Senior Scientist, siRNA Synthesis
AbbVie
Principal Scientist - Mid/Large Scale Oligonucleotide Synthesis, xRNA Therapeutics
Diversity Employment